For research use only. Not for therapeutic Use.
Exbivirumab（Cat No.:I042110）is an investigational monoclonal antibody being developed for the treatment of viral infections, particularly respiratory syncytial virus (RSV). It works by binding to the RSV F protein, preventing the virus from entering and infecting human cells. Exbivirumab is designed to neutralize RSV and potentially reduce the severity of infections, especially in high-risk populations such as infants, elderly individuals, and immunocompromised patients. It is undergoing clinical trials to assess its safety, efficacy, and potential to be used as a therapeutic option or prophylactic treatment against RSV infections.
| Catalog Number | I042110 |
| CAS Number | 569658-80-6 |
| Purity | ≥95% |
